Targeting Breast Cancer with Dasatinib Derivatives: A Multi-Parameter Strategy to Uncover Potent Lead Compounds
Abdulaziz Mohammed Asiri, Amer Ali Ahmad Al Ali and Mohammed Haidar Abu-Alghayth Author informationCitations Corresponding author. Correspondence: Abdulaziz Asiri Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Bisha, Bisha 67714, P.O. Box 255, SAUDI ARABIA. Email: [email protected] Author Notes May 21, 2024; June 18, 2024; August 23, 2024. Copyright and License
Authors
- Mohammed H. Abu-Alghayth (ORCID: https://orcid.org/0009-0008-0125-4041)
- Abdulaziz Mohammed Asiri
- Amer Ali Ahmad Al Ali
Publication Details
- Journal
- International Journal of Pharmaceutical Investigation
- Published
- 2024-09-27
- DOI
- https://doi.org/10.5530/ijpi.14.4.139
- Citations
- 2
- Primary Topic
- Synthesis and biological activity
- Type
- article
- Field-Weighted Citation Impact
- 0.50